首页 > 最新文献

GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark最新文献

英文 中文
In vitro efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis 肝硬化患者血浆中直接口服抗凝剂的体外疗效观察
C. Pereira, MG Zermatten, M. Fraga, D. Bertaggia-Calderara, A. Aliotta, L. Veuthey, D. Shehwar, D. Moradpour, L. Alberio
{"title":"In vitro efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis","authors":"C. Pereira, MG Zermatten, M. Fraga, D. Bertaggia-Calderara, A. Aliotta, L. Veuthey, D. Shehwar, D. Moradpour, L. Alberio","doi":"10.1055/s-0042-1760483","DOIUrl":"https://doi.org/10.1055/s-0042-1760483","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121112234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of Syk-inhibition on 5B9 monoclonal HIT antibody-mediated procoagulant platelet formation syk抑制对5B9单克隆HIT抗体介导的促凝血小板形成的影响
P. Wurmbäck, J. Zlámal, T. Bakchoul
{"title":"The impact of Syk-inhibition on 5B9 monoclonal HIT antibody-mediated procoagulant platelet formation","authors":"P. Wurmbäck, J. Zlámal, T. Bakchoul","doi":"10.1055/s-0042-1760618","DOIUrl":"https://doi.org/10.1055/s-0042-1760618","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"136 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116330958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring of unfractionated heparin in critical ill ICU patients: a prospective study comparing aPTT and point-of-care viscoelastic testing with IN /HI ratio to anti-Xa 危重重症ICU患者未分级肝素监测:一项比较aPTT和点护理粘弹性试验in /HI比抗xa的前瞻性研究
L. Heubner, A. Dietze, O. Tiebel, A. Güldner, O. Vicent, J. Beyer-Westendorf, T. Koch, P. Spieth
{"title":"Monitoring of unfractionated heparin in critical ill ICU patients: a prospective study comparing aPTT and point-of-care viscoelastic testing with IN /HI ratio to anti-Xa","authors":"L. Heubner, A. Dietze, O. Tiebel, A. Güldner, O. Vicent, J. Beyer-Westendorf, T. Koch, P. Spieth","doi":"10.1055/s-0042-1760501","DOIUrl":"https://doi.org/10.1055/s-0042-1760501","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124132542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adults with severe or moderately severe haemophilia B receiving etranacogene dezaparvovec in the HOPE-B phase 3 trial experience a stable increase in mean Factor IX activity levels and durable haemostatic protection after 24 months’ follow-up 在HOPE-B iii期试验中,接受dezaparvovec的重度或中度血友病B成人患者在24个月的随访后,平均因子IX活性水平稳定增加,并具有持久的止血保护作用
W. S. Pipe, WG F Leebeek, M. Recht, S. Key, S. Lattimore, G. Castaman, M. Coppens, D. Cooper, R. Gut, S. Slawka, S. Verweij, R. Dolmetsch, Y. Li, P. Monahan, W. Miesbach
{"title":"Adults with severe or moderately severe haemophilia B receiving etranacogene dezaparvovec in the HOPE-B phase 3 trial experience a stable increase in mean Factor IX activity levels and durable haemostatic protection after 24 months’ follow-up","authors":"W. S. Pipe, WG F Leebeek, M. Recht, S. Key, S. Lattimore, G. Castaman, M. Coppens, D. Cooper, R. Gut, S. Slawka, S. Verweij, R. Dolmetsch, Y. Li, P. Monahan, W. Miesbach","doi":"10.1055/s-0042-1760523","DOIUrl":"https://doi.org/10.1055/s-0042-1760523","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125430162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of enhanced platelet turnover on platelet reactivity in healthy humans 增强血小板周转对健康人血小板反应性的影响
L. S. Schwarz, M. Wolff, A. Greinacher, S. Handtke, T. Thiele
{"title":"The impact of enhanced platelet turnover on platelet reactivity in healthy humans","authors":"L. S. Schwarz, M. Wolff, A. Greinacher, S. Handtke, T. Thiele","doi":"10.1055/s-0042-1760593","DOIUrl":"https://doi.org/10.1055/s-0042-1760593","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"118 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124544427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of recombinant Factor IX fusion protein (rIX-FP) in previously untreated patients with haemophilia B 重组因子IX融合蛋白(rIX-FP)在未经治疗的B型血友病患者中的安全性和有效性
R. Lemons, M. Wang, J. Curtin, M. L. Lepatan, C. Male, F. Peyvandi, M. von Depka, R. Wang, W. McKeand, W. Seifert, J. Oldenburg
{"title":"Safety and efficacy of recombinant Factor IX fusion protein (rIX-FP) in previously untreated patients with haemophilia B","authors":"R. Lemons, M. Wang, J. Curtin, M. L. Lepatan, C. Male, F. Peyvandi, M. von Depka, R. Wang, W. McKeand, W. Seifert, J. Oldenburg","doi":"10.1055/s-0042-1760518","DOIUrl":"https://doi.org/10.1055/s-0042-1760518","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"87 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115862995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II 利用MHC II类上呈现的免疫显性FVIII衍生肽,探索红细胞作为因子VIII抑制剂的新耐受性途径
M. Miranda, E. Brandsma, P. Kaijen, F. V. van Alphen, R. van Bruggen, K. Fijnvandraat, S. Lacroix-Desmazes, J. Voorberg
{"title":"Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II","authors":"M. Miranda, E. Brandsma, P. Kaijen, F. V. van Alphen, R. van Bruggen, K. Fijnvandraat, S. Lacroix-Desmazes, J. Voorberg","doi":"10.1055/s-0042-1760520","DOIUrl":"https://doi.org/10.1055/s-0042-1760520","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130330992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-PF4 antibodies after SARS-CoV-2 vaccines: long term follow-up SARS-CoV-2疫苗后的抗pf4抗体:长期随访
G. Uzun, K. Althaus, B. Luz, M. Wolf, H. Henkes, T. Bakchoul
{"title":"Anti-PF4 antibodies after SARS-CoV-2 vaccines: long term follow-up","authors":"G. Uzun, K. Althaus, B. Luz, M. Wolf, H. Henkes, T. Bakchoul","doi":"10.1055/s-0042-1760583","DOIUrl":"https://doi.org/10.1055/s-0042-1760583","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126049053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the interaction of circulating von Willebrand factor with polymorphonuclear leukocytes ex vivo 体外研究循环血管性血友病因子与多形核白细胞的相互作用
H. Yadegari, A. Kuanyshbek, NS Hamedani, J. Oldenburg
{"title":"Investigating the interaction of circulating von Willebrand factor with polymorphonuclear leukocytes ex vivo","authors":"H. Yadegari, A. Kuanyshbek, NS Hamedani, J. Oldenburg","doi":"10.1055/s-0042-1760454","DOIUrl":"https://doi.org/10.1055/s-0042-1760454","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127746244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Durability of bleeding protection and Factor IX activity in individuals with and without adeno-associated virus serotype 5 neutralising antibodies (Titres <1:700) in the phase 3 HOPE-B trial of etranacogene dezaparvovec gene therapy for haemophilia B 在dezaparvovec基因治疗B型血友病的3期HOPE-B试验中,携带和不携带腺相关病毒血清5型中和抗体(滴度<1:700)的个体的出血保护持久性和因子IX活性
W. S. Pipe, WG F Leebeek, M. Recht, S. Key, S. Lattimore, G. Castaman, D. Cooper, S. Verweij, R. Dolmetsch, J. Tarrant, Y. Li, E. P. Monahan, W. Miesbach
{"title":"Durability of bleeding protection and Factor IX activity in individuals with and without adeno-associated virus serotype 5 neutralising antibodies (Titres <1:700) in the phase 3 HOPE-B trial of etranacogene dezaparvovec gene therapy for haemophilia B","authors":"W. S. Pipe, WG F Leebeek, M. Recht, S. Key, S. Lattimore, G. Castaman, D. Cooper, S. Verweij, R. Dolmetsch, J. Tarrant, Y. Li, E. P. Monahan, W. Miesbach","doi":"10.1055/s-0042-1760524","DOIUrl":"https://doi.org/10.1055/s-0042-1760524","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127117426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1